Drug Type Small molecule drug |
Synonyms 复方盐酸雷尼替丁 |
Target |
Mechanism H2 receptor antagonists(Histamine H2 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (11 Dec 2007), |
Regulation- |
Molecular FormulaC13H23ClN4O3S |
InChIKeyGGWBHVILAJZWKJ-UHFFFAOYSA-N |
CAS Registry66357-59-3 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Duodenal Ulcer | CN | 11 Dec 2007 | |
Helicobacter pylori infection | CN | 11 Dec 2007 | |
Stomach Ulcer | CN | 11 Dec 2007 |